Wuzhi Tablet (Schisandra sphenanthera Extract) Is a Promising Tacrolimus-Sparing Agent for Renal Transplant Recipients Who Are CYP3A5 Expressers: a Two-Phase Prospective Study
Jiali Li(Henan University), Min Huang(Sun Yat-sen University), Qian Fu(Beijing Normal University), Huichang Bi(Southern Medical University), Longshan Liu(Sun Yat-sen University), Xiaoling Qin(Sun Yat-sen University), Yu Zhang(Union Hospital), Changxi Wang(Sun Yat-sen University), Siyang Chen(Purdue University West Lafayette), Xueding Wang(Sun Yat-sen University)
Cited by 38
Related Papers
Antibody drug conjugate: the “biological missile” for targeted cancer therapy
|Signal Transduction and Targeted Therapy|2022|1.5k
Current trends in drug metabolism and pharmacokinetics
|Acta Pharmaceutica Sinica B|2019|391
Caution on Kidney Dysfunctions of COVID-19 Patients
|SSRN Electronic Journal|2020|140
SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation
|Acta Pharmaceutica Sinica B|2020|129
Optimization of harvesting, extraction, and analytical protocols for UPLC-ESI-MS-based metabolomic analysis of adherent mammalian cancer cells
|Analytical and Bioanalytical Chemistry|2013|126